健康大视野·医学分册2023，Issue(13) ：297-298.DOI:10.3969/j.issn.1005-0019.2023.13.128

复发性流产常用抗凝及抗血小板药物妊娠期暴露的安全性进展

Progress in the safety of anticoagulant and antiplatelet drugs commonly used in recurrent abortion during pregnancy exposure

牟莎莎 高玉盛 马吉红
健康大视野·医学分册2023，Issue(13) ：297-298.DOI:10.3969/j.issn.1005-0019.2023.13.128
✕
  • 万方数据

复发性流产常用抗凝及抗血小板药物妊娠期暴露的安全性进展

Progress in the safety of anticoagulant and antiplatelet drugs commonly used in recurrent abortion during pregnancy exposure

牟莎莎 1高玉盛 1马吉红1
扫码查看

作者信息

  • 1. 青岛市胶州中心医院,山东 青岛 266300
  • 折叠

摘要

目的:复发性流产抗凝及抗血小板药物的应用安全性.方法:取3-4年之间在青岛市胶州中心医院产检并诊断为复发性流产患者共200例,随机数字表法分为对照组和观察组各100例.对照组患者在基础治疗后给予阿司匹林药物治疗,观察组患者在对照组基础上给予低分子量肝素钠药物治疗.对比两组患者治疗情况、相关指标情况、不良反应发生情况.结果:观察组各项指标均优于对照组(P＜0.05).结论:针对复发性流产患者给予抗凝药物联合抗血小板药物可提高安全性,可在临床上应用.

Abstract

Objective To evaluate the safety of recurrent miscarriage anticoagulants and Antiplatelet drug. Methods: a total of 200 patients with recurrent miscarriage at Jiaozhou central hospital in Qingdao during 3-4 years were randomly divided into control group and Observation Group. Patients in the control group were treated with aspirin after basic treatment, while patients in the observation group were treated with low molecular weight heparin sodium on the basis of the control group. The treatment, related indexes and adverse reactions were compared between the two groups. Results: all the indexes in the observation group were better than those in the control group (P & Lt; 0.05) . Conclusion: anticoagulants combined with Antiplatelet drug for recurrent miscarriage patients can improve safety and can be used clinically.

关键词

复发性流产/抗凝/抗血小板药物/妊娠期/暴露/安全性

Key words

recurrent abortion/Anticoagulation/Antiplatelet drugs/Gestation period/To be exposed/security

引用本文复制引用

出版年

2023
健康大视野·医学分册
中国保健协会

健康大视野·医学分册

ISSN：1005-0019
参考文献量6
段落导航相关论文